ANTICOAGULATION THERAPY AND PRIMARY-CARE INTERNAL-MEDICINE - A NURSE PRACTITIONER MODEL FOR COMBINED CLINICAL SERVICE

被引:5
作者
BECKER, DM
DEMONG, LK
KAPLAN, P
HUTCHINSON, R
CALLAHAN, CM
FIHN, SD
WHITE, RH
机构
[1] University of Virginia Health Sciences Center, Charlottesville, Virginia
[2] University of California at Davis, Medical Center, Davis, California
[3] Seattle Va Medical Center, Seattle, Washington
[4] University of Virginia Health Sciences Center, Charlottesville, Virginia
关键词
ANTICOAGULATION; NURSE PRACTITIONERS; PROTHROMBIN TIME MONITORS; WARFARIN;
D O I
10.1007/BF02599227
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The anticoagulation clinics at the University of Virginia Health Sciences Center and the University of California at Davis Medical Center are nurse-practitioner-operated, are affiliated with the general medicine clinic, and rely on portable prothrombin time (PT) monitors that use whole blood and provide timely as well as accurate results reported in PT seconds or as the international normalized ratio (INR). On-site PT/INR testing at these clinics simplifies anticoagulation, mandates direct patient contact, and facilitates primary as well as comprehensive care for patients requiring multispecialty services in large tertiary care centers. Encounters are relatively brief, averaging 19 minutes; 72% of the encounter time involves anticoagulation care and 28% involves primary care. Anticoagulation results using portable PT/INR monitors are safe and accurate based on comparisons with results from clinics relying on standard instruments.
引用
收藏
页码:525 / 527
页数:3
相关论文
共 11 条
  • [1] David F.B., Estruch M.T., Saon-Corvera E.B., Voight G.C., Tobin J.D., Management of anticoagulation in outpatients. Experience with an anticoagulation service in a municipal hospital setting, Arch Intern Med, 137, pp. 197-202, (1977)
  • [2] Errichetti A.M., Holden A., Ansell J., Management of oral anticoagulant therapy. Experience with an anticoagulation clinic, Arch Intern Med, 144, (1984)
  • [3] Bussey H.I., Rospond R.M., Quandt C.M., Clark G.M., The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic, Pharmacotherapy, 9, (1989)
  • [4] Cohen I.A., Hutchinson T.A., Kirking D.M., Shue M.E., Evaluation of pharmacist-managed anticoagulation clinic, J Clin Hosp Pharm, 10, (1985)
  • [5] McCurdy S.A., White R.H., Accuracy and precision of a portable anticoagulation monitor in a clinical setting, Arch Intern Med, 152, (1992)
  • [6] Becker D.M., Humphries J.E., Walker F.B., DeMong L.K., Bopp J.S., Acker M.N., Standardizing the prothrombin time: calibrating coagulation instruments as well as thromboplastin, Arch Pathol Lab Med, 117, (1993)
  • [7] White R.H., Becker D.M., Gunther-Maher M.G., Experience using a portable monitor to monitor anticoagulant therapy, South Med J, 87, (1994)
  • [8] Fihn S.D., McDonell M., Martin D., Et al., Risk factors for complications of chronic anticoagulation—a multicenter study, Ann Intern Med, 118, (1993)
  • [9] Fihn S.D., McDonell M.B., Vermes D., Et al., A computerized intervention to improve timing of outpatient follow-up—a multicenter randomized trial in patients treated with warfarin, J Gen Intern Med, 9, (1994)
  • [10] Hirsh J., Standard monitoring of warfarin in North America: time for a change, Arch Intern Med, 152, (1992)